Search Results - "Finetti, Pascal"

Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies.

Authors: Kfoury, Maria Finetti, Pascal Mamessier, Emilie et al.

Source: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p11953. 13p.

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.

Authors: Mogenet, Alice Finetti, Pascal Denicolai, Emilie et al.

Source: Journal of Translational Medicine. 9/19/2023, Vol. 21 Issue 1, p1-11. 11p.

Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype.

Authors: de Nonneville, Alexandre Finetti, Pascal Boudin, Laurys et al.

Source: Pharmaceutics. Mar2023, Vol. 15 Issue 3, p938. 15p.

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing.

Authors: Guille, Arnaud Adélaïde, José Finetti, Pascal et al.

Source: Briefings in Bioinformatics; Jan2025, Vol. 26 Issue 1, p1-11, 11p

WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer.

Authors: de Nonneville, Alexandre Finetti, Pascal Birnbaum, Daniel et al.

Source: Advanced Science. 9/8/2021, Vol. 8 Issue 17, p1-3. 3p.

Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results.

Authors: Manai, Maroua Finetti, Pascal Mejri, Nesrine et al.

Source: Molecular & Clinical Oncology. Feb2019, Vol. 10 Issue 2, p223-230. 8p.

Validation and comparison of the molecular classifications of pancreatic carcinomas.

Authors: Birnbaum, David J. Finetti, Pascal Birnbaum, Daniel et al.

Source: Molecular Cancer. 11/6/2017, Vol. 16, p1-7. 7p. 1 Diagram, 1 Chart, 1 Graph.

A 25-gene classifier predicts overall survival in resectable pancreatic cancer.

Authors: Birnbaum, David J. Finetti, Pascal Lopresti, Alexia et al.

Source: BMC Medicine. 9/20/2017, Vol. 15, p1-14. 14p. 5 Charts, 2 Graphs.

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.

Authors: Sabatier, Renaud Finetti, Pascal Guille, Arnaud et al.

Source: Molecular Cancer. 10/2/2014, Vol. 13, p1-14. 14p. 3 Charts, 4 Graphs.

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer.

Authors: Sabatier, Renaud Finetti, Pascal Adelaide, José et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 11, p1-8. 8p.

High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes.

Authors: Bekhouche, Ismahane Finetti, Pascal Adelaïde, José et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 2, p1-13. 13p.

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.

Authors: Bertucci, François Finetti, Pascal Ginestier, Christophe et al.

Source: Oncogene. 2/19/2004, Vol. 23 Issue 7, p1377-1391. 15p. 9 Diagrams, 3 Charts, 6 Graphs.

CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response.

Authors: de Nonneville, Alexandre Finetti, Pascal Picard, Maelle et al.

Source: Cancers. Mar2022, Vol. 14 Issue 5, p1306. 1p.

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma.

Authors: Billon, Emilien Finetti, Pascal Bertucci, Alexandre et al.

Source: OncoImmunology. 2019, Vol. 8 Issue 11, p1-11. 11p.

Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer.

Authors: Hussain, Zainab Bertran, Thomas Finetti, Pascal et al.

Source: Cell Communication & Signaling. 1/2/2024, Vol. 22 Issue 1, p1-17. 17p.

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer.

Authors: Daulat, Avais M. Finetti, Pascal Revinski, Diego et al.

Source: British Journal of Cancer. Apr2019, Vol. 120 Issue 9, p931-940. 10p. 1 Color Photograph, 1 Diagram, 2 Charts, 2 Graphs.

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.

Authors: Bertucci, François Finetti, Pascal Simeone, Ines et al.

Source: British Journal of Cancer. Nov2018, Vol. 119 Issue 11, p1383-1391. 9p. 3 Charts, 3 Graphs.

Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy.

Authors: Devi, Gayathri R. Finetti, Pascal Morse, Michael A. et al.

Source: Cancers. Jun2021, Vol. 13 Issue 11, p2807. 1p.

Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?

Authors: Aulas, Anaïs Finetti, Pascal Lyons, Shawn M. et al.

Source: Cancers. Sep2020, Vol. 12 Issue 9, p2470. 1p.

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC.

Authors: Doghman-Bouguerra, Mabrouka Finetti, Pascal Durand, Nelly et al.

Source: Cancers. Mar2020, Vol. 12 Issue 3, p689. 1p.